NCT05984615View on ClinicalTrials.gov

Real-world Evaluation of the Impact of Baseline Metastases on Clinical Outcomes Among BRAF Positive Metastatic Melanoma Patients

CompletedOBSERVATIONAL
Enrollment

1,961

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

August 24, 2022

Study Completion Date

August 24, 2022

Conditions
BRAF Positive Metastatic Melanoma
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY